PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
From:
J Immunol Methods. Author manuscript; available in PMC 2012 October 28.
Published in final edited form as:
J Immunol Methods. 2011 October 28; 373(1-2): 111–126.
Published online 2011 August 18. doi: 10.1016/j.jim.2011.08.007

Figure 1

An external file that holds a picture, illustration, etc.
Object name is nihms323952f1.jpg
Scheme to identify enhanced peptide ligands of PSA epitope, HL10

A) Mutations were introduced into the HL10 epitope using degenerate oligonucleotides, which when expressed result in random amino acid substitutions. N represents any one of 4 bases; X represents any given amino acid codon. A library was generated for each position of the peptide epitope. B) Illustration of the oligonucleotides corresponding to the epitope region used to generate altered peptide ligand (APL) sequences. C) Sequences encoding APL products were cloned into the pQE40 vector and transformed en mass into E. coli. Ninety individual colonies were picked and arrayed into wells of a 96 well plate. This procedure was conducted for each position within the sequence of the HL10 epitope to generate the ten individual positional mutant libraries. The bacterial clones were subsequently expressed, lysed in individual wells of 96 well plate, and individually coupled to tosyl-activated magnetic beads that were then used as a source of antigen in the functional assay.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7
  • Figure 8
  • Figure 9
Click on the image to see a larger version.